⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CABA News
Cabaletta Bio, Inc. Common Stock
Cabaletta Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
CABA
Form 8-K
sec.gov
CABA
Orphan Drugs Market Outlook 2026-2030: Investment Trends, Strategic Profiles and Revenue Share Outlook
globenewswire.com
SNY
CABA
Form 8-K
sec.gov
CABR
CABA
Cabaletta Bio to Participate in Upcoming Investor Conferences
globenewswire.com
CABA
Form 8-K
sec.gov
CABR
CABA
Form 8-K
sec.gov
CABA
Cabaletta Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
CABA
Form 8-K
sec.gov
CABR
CABA
Form 8-K
sec.gov
CABR
CABA